During the period 2016 to 2019, Melbourne Genomics Health Alliance is providing genomic sequencing to patients in 11 areas of focus.
These 11 disease areas were selected by experts as those where genomic sequencing is most likely to benefit patient care, in comparison with current approaches. This range of very different conditions – spanning adult and paediatric medicine and bacterial analysis – also allows optimal evaluation of genomics’ effectiveness broadly in practice.
Patients invited to participate will have genomic sequencing at the same time as their usual care. The outcomes of each approach will be compared, to understand how genomic sequencing can be most usefully applied by doctors for the benefit of patients.
The five areas of focus during the period 2017 to 2019 are:
- Bone marrow failure
- Controlling superbugs
- Complex neurological and neurodegenerative diseases
- Genetic kidney disease
- Perinatal autopsy
The six areas of focus during the period 2016 to 2018 are: